Rani Therapeutics Holdings Stock Price History
RANI Stock | USD 1.31 0.01 0.76% |
If you're considering investing in Rani Stock, it is important to understand the factors that can impact its price. As of today, the current price of Rani Therapeutics stands at 1.31, as last reported on the 18th of January 2025, with the highest price reaching 1.35 and the lowest price hitting 1.31 during the day. Rani Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.25, which implies the firm had a -0.25% return per unit of risk over the last 3 months. Rani Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rani Therapeutics' Variance of 40.38, coefficient of variation of (568.95), and Risk Adjusted Performance of (0.14) to confirm the risk estimate we provide.
As of now, Rani Therapeutics' Total Stockholder Equity is increasing as compared to previous years. The Rani Therapeutics' current Liabilities And Stockholders Equity is estimated to increase to about 86.4 M, while Common Stock Shares Outstanding is projected to decrease to under 23.9 M. . As of now, Rani Therapeutics' Price Book Value Ratio is increasing as compared to previous years. The Rani Therapeutics' current Price To Book Ratio is estimated to increase to 6.22, while Price To Sales Ratio is projected to decrease to 129.59. Rani Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Rani |
Sharpe Ratio = -0.2469
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | RANI |
Estimated Market Risk
4.05 actual daily | 36 64% of assets are more volatile |
Expected Return
-1.0 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.25 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Rani Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rani Therapeutics by adding Rani Therapeutics to a well-diversified portfolio.
Price Book 13.9866 | Enterprise Value Ebitda (1.42) | Price Sales 313.1706 | Shares Float 20.4 M | Wall Street Target Price 11.5 |
Rani Therapeutics Stock Price History Chart
There are several ways to analyze Rani Stock price data. The simplest method is using a basic Rani candlestick price chart, which shows Rani Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | November 11, 2024 | 2.62 |
Lowest Price | January 10, 2025 | 1.25 |
Rani Therapeutics January 18, 2025 Stock Price Synopsis
Various analyses of Rani Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Rani Stock. It can be used to describe the percentage change in the price of Rani Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Rani Stock.Rani Therapeutics Price Action Indicator | (0.03) | |
Rani Therapeutics Price Rate Of Daily Change | 0.99 | |
Rani Therapeutics Price Daily Balance Of Power | (0.25) |
Rani Therapeutics January 18, 2025 Stock Price Analysis
Rani Stock Price History Data
The price series of Rani Therapeutics for the period between Sun, Oct 20, 2024 and Sat, Jan 18, 2025 has a statistical range of 1.93 with a coefficient of variation of 24.28. The price distribution for the period has arithmetic mean of 1.96. The median price for the last 90 days is 2.0.Open | High | Low | Close | Volume | ||
01/18/2025 | 1.32 | 1.35 | 1.31 | 1.31 | ||
01/17/2025 | 1.32 | 1.35 | 1.31 | 1.31 | 121,282 | |
01/16/2025 | 1.31 | 1.34 | 1.27 | 1.32 | 171,804 | |
01/15/2025 | 1.30 | 1.32 | 1.27 | 1.31 | 154,072 | |
01/14/2025 | 1.30 | 1.32 | 1.26 | 1.28 | 180,293 | |
01/13/2025 | 1.27 | 1.31 | 1.24 | 1.30 | 266,550 | |
01/10/2025 | 1.39 | 1.39 | 1.25 | 1.25 | 557,498 | |
01/08/2025 | 1.42 | 1.48 | 1.34 | 1.36 | 437,087 | |
01/07/2025 | 1.50 | 1.54 | 1.42 | 1.43 | 181,953 | |
01/06/2025 | 1.58 | 1.60 | 1.46 | 1.49 | 374,959 | |
01/03/2025 | 1.45 | 1.61 | 1.45 | 1.53 | 525,099 | |
01/02/2025 | 1.38 | 1.48 | 1.38 | 1.46 | 384,852 | |
12/31/2024 | 1.50 | 1.50 | 1.36 | 1.37 | 596,938 | |
12/30/2024 | 1.38 | 1.55 | 1.35 | 1.48 | 550,099 | |
12/27/2024 | 1.37 | 1.50 | 1.36 | 1.42 | 525,643 | |
12/26/2024 | 1.40 | 1.45 | 1.37 | 1.42 | 490,363 | |
12/24/2024 | 1.40 | 1.44 | 1.36 | 1.42 | 223,632 | |
12/23/2024 | 1.40 | 1.52 | 1.37 | 1.42 | 492,359 | |
12/20/2024 | 1.31 | 1.42 | 1.30 | 1.40 | 461,222 | |
12/19/2024 | 1.38 | 1.42 | 1.30 | 1.30 | 576,776 | |
12/18/2024 | 1.41 | 1.53 | 1.33 | 1.33 | 1,138,195 | |
12/17/2024 | 1.62 | 1.64 | 1.44 | 1.46 | 914,325 | |
12/16/2024 | 1.63 | 1.72 | 1.58 | 1.59 | 814,011 | |
12/13/2024 | 1.77 | 1.77 | 1.60 | 1.66 | 694,688 | |
12/12/2024 | 1.85 | 1.87 | 1.74 | 1.74 | 585,621 | |
12/11/2024 | 1.90 | 1.92 | 1.85 | 1.86 | 280,599 | |
12/10/2024 | 1.93 | 2.00 | 1.88 | 1.90 | 382,579 | |
12/09/2024 | 1.97 | 1.97 | 1.92 | 1.93 | 315,582 | |
12/06/2024 | 1.85 | 1.97 | 1.85 | 1.93 | 409,949 | |
12/05/2024 | 1.91 | 1.95 | 1.85 | 1.85 | 473,555 | |
12/04/2024 | 1.97 | 1.97 | 1.90 | 1.93 | 408,482 | |
12/03/2024 | 1.99 | 2.04 | 1.93 | 1.96 | 382,787 | |
12/02/2024 | 2.03 | 2.04 | 1.90 | 2.00 | 802,513 | |
11/29/2024 | 2.00 | 2.03 | 1.99 | 2.02 | 254,467 | |
11/27/2024 | 1.96 | 2.03 | 1.95 | 1.99 | 557,932 | |
11/26/2024 | 2.07 | 2.10 | 1.94 | 1.95 | 746,076 | |
11/25/2024 | 2.08 | 2.16 | 2.06 | 2.08 | 635,401 | |
11/22/2024 | 2.07 | 2.12 | 2.04 | 2.08 | 414,943 | |
11/21/2024 | 2.04 | 2.08 | 2.01 | 2.04 | 340,314 | |
11/20/2024 | 2.07 | 2.10 | 2.00 | 2.05 | 421,296 | |
11/19/2024 | 2.03 | 2.06 | 2.00 | 2.06 | 543,950 | |
11/18/2024 | 2.26 | 2.29 | 2.00 | 2.05 | 1,354,119 | |
11/15/2024 | 2.37 | 2.37 | 2.23 | 2.27 | 304,460 | |
11/14/2024 | 2.42 | 2.47 | 2.26 | 2.35 | 700,079 | |
11/13/2024 | 2.55 | 2.59 | 2.45 | 2.47 | 278,506 | |
11/12/2024 | 2.62 | 2.67 | 2.55 | 2.57 | 334,935 | |
11/11/2024 | 2.41 | 2.63 | 2.41 | 2.62 | 612,009 | |
11/08/2024 | 2.54 | 2.54 | 2.32 | 2.41 | 632,574 | |
11/07/2024 | 2.50 | 2.56 | 2.42 | 2.51 | 530,721 | |
11/06/2024 | 2.47 | 2.62 | 2.42 | 2.48 | 770,331 | |
11/05/2024 | 2.44 | 2.47 | 2.34 | 2.43 | 362,495 | |
11/04/2024 | 2.33 | 2.48 | 2.25 | 2.41 | 911,649 | |
11/01/2024 | 2.33 | 2.33 | 2.22 | 2.31 | 432,644 | |
10/31/2024 | 2.34 | 2.34 | 2.22 | 2.29 | 382,944 | |
10/30/2024 | 2.34 | 2.36 | 2.28 | 2.32 | 540,607 | |
10/29/2024 | 2.29 | 2.41 | 2.26 | 2.34 | 781,682 | |
10/28/2024 | 2.41 | 2.57 | 2.19 | 2.31 | 1,872,374 | |
10/25/2024 | 2.37 | 2.52 | 2.32 | 2.34 | 817,450 | |
10/24/2024 | 2.50 | 2.61 | 2.37 | 2.39 | 739,851 | |
10/23/2024 | 2.39 | 2.58 | 2.31 | 2.52 | 1,303,687 | |
10/22/2024 | 2.50 | 2.55 | 2.35 | 2.38 | 1,557,584 |
About Rani Therapeutics Stock history
Rani Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rani is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rani Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rani Therapeutics stock prices may prove useful in developing a viable investing in Rani Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 29.3 M | 23.9 M | |
Net Loss | -55.1 M | -52.3 M |
Rani Therapeutics Quarterly Net Working Capital |
|
Rani Therapeutics Stock Technical Analysis
Rani Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
All Next | Launch Module |
Rani Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Rani Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Rani Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rani to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.14) | |||
Jensen Alpha | (1.15) | |||
Total Risk Alpha | (1.28) | |||
Treynor Ratio | (1.22) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Rani Stock analysis
When running Rani Therapeutics' price analysis, check to measure Rani Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rani Therapeutics is operating at the current time. Most of Rani Therapeutics' value examination focuses on studying past and present price action to predict the probability of Rani Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rani Therapeutics' price. Additionally, you may evaluate how the addition of Rani Therapeutics to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |